| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |